Procedure market
China Scoliosis Treatment Market Outlook 2026
China's scoliosis treatment market is sized at USD 1.42 billion in 2025 with a 9.6% CAGR forecast through 2030, driven by adolescent idiopathic scoliosis screening expansion and growing adult deformity surgery volume.
Market size (2025)
USD 1.42 billion
CAGR
9.6%
Forecast (2030)
USD 2.24 billion
Geography
Mainland China (Class A teaching hospitals and major private spine centres)
International-patient cost band
$18,000–$38,000 USD
Market size, 2021–2030
Mainland China (Class A teaching hospitals and major private spine centres).
| Year | Market size (USD) | Status |
|---|---|---|
| 2021 | USD 880 million | Historical |
| 2022 | USD 980 million | Historical |
| 2023 | USD 1.11 billion | Historical |
| 2024 | USD 1.26 billion | Historical |
| 2025 | USD 1.42 billion | Latest actual |
| 2026 | USD 1.56 billion | Forecast |
| 2030 | USD 2.24 billion | Forecast |
Demand drivers
- National adolescent idiopathic scoliosis (AIS) screening rollout — provincial screening programmes added in 18 provinces since 2022.
- Aging population: adult degenerative scoliosis cases growing ~12% per year.
- Reimbursement expansion for primary thoracolumbar fusion under provincial DRG bundles.
- Improved access to motion-preserving alternatives (VBT, MAGEC growing rods).
Supply-side landscape
- Top-volume centres: PUMCH, PKU Third Hospital, Xinhua Shanghai, West China Hospital, Sun Yat-sen Memorial Hospital.
- International-brand hardware (Medtronic CD Horizon, DePuy Expedium, Stryker Xia) dominates premium volumes; Chinese hardware (Weigao, Trauson) grows in DRG-priced segments.
- International-patient demand concentrated in Beijing and Shanghai centres with intra-operative neuromonitoring and English-speaking coordination.
Risks & headwinds
- DRG bundling pressure on hardware margins.
- Late-presenting adolescent cases with high Cobb angles require complex revision — longer LOS, higher complication rates.
- VBT (anterior tethering) outcomes data still maturing; long-term reoperation rates remain uncertain.
Notable providers
Class A
PKU Third Hospital
Highest-volume scoliosis service in Beijing; complex adult deformity and revision.
Class APUMCH Orthopedics
Adolescent idiopathic scoliosis with intra-operative neuromonitoring.
Class AXinhua Shanghai
Paediatric scoliosis and growing-rod programme.
Class AWest China Hospital
Tier-2 city pricing for routine AIS correction with Class A volumes.
Related on this site
Specialty hubFull specialty pillar page
Frequently asked
- How big is the China scoliosis treatment market in 2026?
- USD 1.42 billion in 2025 with a forecast to USD 1.56 billion in 2026 and USD 2.24 billion by 2030 (9.6% CAGR). Growth is driven by adolescent screening rollout and adult degenerative deformity volume.
- Which hospitals dominate scoliosis surgery in China?
- PKU Third Hospital, PUMCH, Xinhua Shanghai, West China Hospital and Sun Yat-sen Memorial Hospital. All five operate Class A spine services with intra-operative neuromonitoring.
- How much does scoliosis surgery cost in China?
- USD 18,000–38,000 all-in for adolescent idiopathic scoliosis correction at a Class A international department, including international-brand instrumentation, 10–14 days inpatient and 12-month follow-up.
Sources
- National Health Commission DRG payment data 2023–2025
- Chinese Orthopaedic Association annual deformity-surgery volume report 2024
- Frost & Sullivan China Spine Devices Market Outlook 2026
- Partner-network 2026 international-patient quote data
Last reviewed: 2026-05-12.
Going beyond the report
For a written quote from two Class A international departments — covering procedure, hospital match, recovery and visa — start the quote wizard.